STANDARDIZATION OF CATIONIC DERIVATIVE OF BAKTERIOPURPURINIMID AS PHARMACEUTICAL SUBSTANCE FOR ANTIMICROBIAL PHOTODYNAMIC THERAPYA

In this paper key indicators due to Pharmacopoeia XIII [1] that can be used to standardize the cationic derivative of bakteriopurpurinimid as pharmaceutical substance (PS) are presented. The prime application of this compound to be a photosensitiser for antimicrobial photodynamic therapy (PDT).

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: A. M. Frolova, D. A. Grafov, V. S. Tukova, E. V. Vorfolomeeva, N. A. Keryanov, E. V. Feelonenko, A. V. Panov, M. A. Green, S. A. Kedeek
Formaat: Artigo
Taal:Russo
Gepubliceerd in: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-01-01
Reeks:Разработка и регистрация лекарственных средств
Onderwerpen:
standardization
quality control
pharmaceutical substance
antimicrobial photodynamic therapy
cationicderivative
bakteriopurpurinimid
Online toegang:https://www.pharmjournal.ru/jour/article/view/320
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items